|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | (2006.01) |
| A61K 31/337 | (2013.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3600282 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18777520.0 |
| Date of filing the European patent application | 2018-03-30 | |
| (97) | Date of publication of the European application | 2020-02-05 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/025547 |
| Date | 2018-03-30 |
| (87) | Number | WO 2018/183947 |
| Date | 2018-10-04 |
| (30) | Number | Date | Country code |
| 201762480226 P | 2017-03-31 | US |
| (72) |
HUNT, Hazel , US
|
| (73) |
Corcept Therapeutics Incorporated ,
101 Redwood Shores Parkway, Redwood City, CA 94065,
US
|
| (54) | GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT CERVICAL CANCER |
| GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT CERVICAL CANCER |